Related Experiment Videos

Neutrophil-induced endothelial cell damage: inhibition by a 14-membered ring macrolide through the action of nitric

T Mitsuyama1, K Hidaka, T Furuno

  • 1Research Institute for Diseases of the Chest, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Insights

Erythromycin, a macrolide antibiotic, reduces neutrophil activity and protects endothelial cells by increasing nitric oxide release. Clarithromycin did not show these anti-inflammatory effects, suggesting macrolide differences in treating inflammatory diseases.

Area of Science:

  • Pharmacology
  • Immunology
  • Cell Biology

Background:

  • Macrolide antibiotics, like erythromycin, are used for their antibacterial and anti-inflammatory properties.
  • Erythromycin's effectiveness in diffuse panbronchiolitis suggests broader mechanisms beyond simple bacterial inhibition.

Purpose of the Study:

  • To investigate the differential effects of 14-membered ring macrolides (erythromycin and clarithromycin) on human neutrophil function and neutrophil-induced endothelial cell damage.
  • To elucidate the mechanisms underlying erythromycin's protective effects on endothelial cells.

Main Methods:

  • Assessing neutrophil superoxide production and calcium (Ca2+) influx in response to N-formyl-methionyl-leucyl-phenylalanine (fMLP).
  • Co-culturing endothelial cells with neutrophils to evaluate nitric oxide (NO) release and endothelial cell injury.
  • Utilizing carboxy-PTIO to scavenge NO and H-89 to inhibit protein kinase A (PKA) to investigate mechanisms.

Main Results:

  • Erythromycin inhibited neutrophil superoxide production and Ca2+ influx, while clarithromycin did not.
  • Erythromycin enhanced nitric oxide (NO) release from endothelial cells and reduced neutrophil-induced endothelial cell injury, effects not observed with clarithromycin.
  • Erythromycin's protective effect was linked to NO release and involved the cyclic AMP-dependent protein kinase (PKA) pathway.

Conclusions:

  • Erythromycin exhibits anti-inflammatory effects by modulating neutrophil function and enhancing endothelial NO production via PKA.
  • Clarithromycin lacks these specific anti-inflammatory actions on neutrophils and endothelial cells.
  • The therapeutic utility of 14-membered macrolides may vary depending on their impact on neutrophil-endothelial interactions.

Related Concept Videos